These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 9614627

  • 1. Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complications.
    Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y.
    Diabetes Care; 1998 Jun; 21(6):1027. PubMed ID: 9614627
    [No Abstract] [Full Text] [Related]

  • 2. A novel advanced glycation index and its association with diabetes and microangiopathy.
    Sampathkumar R, Balasubramanyam M, Rema M, Premanand C, Mohan V.
    Metabolism; 2005 Aug; 54(8):1002-7. PubMed ID: 16092048
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [Abstract] [Full Text] [Related]

  • 4. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.
    Yamaguchi M, Nakamura N, Nakano K, Kitagawa Y, Shigeta H, Hasegawa G, Ienaga K, Nakamura K, Nakazawa Y, Fukui I, Obayashi H, Kondo M.
    Diabet Med; 1998 Jun; 15(6):458-62. PubMed ID: 9632118
    [Abstract] [Full Text] [Related]

  • 5. Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes.
    Nakamura N, Yamazaki K, Satoh A, Urakaze M, Kobayashi M, Yamabe H, Osawa H, Shirato K, Sugawara T, Nakamura M, Tamura M, Okumura K.
    In Vivo; 2003 Jun; 17(2):177-80. PubMed ID: 12792982
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum.
    Niwa T, Takeda N, Yoshizumi H, Tatematsu A, Ohara M, Tomiyama S, Niimura K.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):837-43. PubMed ID: 8240359
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
    Kerkeni M, Saïdi A, Bouzidi H, Letaief A, Ben Yahia S, Hammami M.
    Diab Vasc Dis Res; 2013 May 29; 10(3):239-45. PubMed ID: 23091285
    [Abstract] [Full Text] [Related]

  • 11. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M.
    Diabetes Metab Res Rev; 2008 Oct 29; 24(7):549-53. PubMed ID: 18613218
    [Abstract] [Full Text] [Related]

  • 12. [Advanced glycation endproduct (AGE)].
    Miyoshi H, Makita Z.
    Nihon Rinsho; 1998 Jan 29; 56 Suppl 3():185-9. PubMed ID: 9513412
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy.
    Zhou H, Tan KC, Shiu SW, Wong Y.
    Nephrol Dial Transplant; 2008 Mar 29; 23(3):927-33. PubMed ID: 18065800
    [Abstract] [Full Text] [Related]

  • 16. Identification of N(omega)-carboxymethylarginine, a new advanced glycation endproduct in serum proteins of diabetic patients: possibility of a new marker of aging and diabetes.
    Odani H, Iijima K, Nakata M, Miyata S, Kusunoki H, Yasuda Y, Hiki Y, Irie S, Maeda K, Fujimoto D.
    Biochem Biophys Res Commun; 2001 Aug 03; 285(5):1232-6. PubMed ID: 11478788
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy.
    Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, Ohashi J, Shimizu I, Fujii Y, Tanimoto M, Makino H.
    Clin Endocrinol (Oxf); 2008 Mar 03; 68(3):442-9. PubMed ID: 17970779
    [Abstract] [Full Text] [Related]

  • 19. [Diabetic nephropathy and TGF-beta].
    Shirai T.
    Nihon Rinsho; 1998 Jan 03; 56 Suppl 3():381-5. PubMed ID: 9513447
    [No Abstract] [Full Text] [Related]

  • 20. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Takeuchi M, Inoue H, Imaizumi T.
    Diabetes Metab Res Rev; 2008 Feb 03; 24(2):109-14. PubMed ID: 17694504
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.